Campbell & CO Investment Adviser LLC Novo Cure LTD Transaction History

Campbell & CO Investment Adviser LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.83 - $24.05 $186,630 - $379,412	15,776 New	15,776 $270,000
Q3 2023 Nov 08, 2023	BUY	$16.15 - $42.35 $749,618 - $1.97 Million	46,416 New	46,416 $749,000
Q2 2022 Aug 09, 2022	BUY	$56.6 - $89.9 $173,535 - $275,633	3,066 New	3,066 $213,000
Q1 2022 May 09, 2022	SELL	$60.15 - $84.52 $433,080 - $608,544	-7,200 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$75.08 - $121.99 $540,576 - $878,328	7,200 New	7,200 $541,000
Q3 2021 Nov 10, 2021	SELL	$116.17 - $194.55 $151,021 - $252,915	-1,300 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$130.4 - $225.58 $169,520 - $293,254	1,300 New	1,300 $288,000
Q1 2020 Apr 29, 2020	SELL	$57.05 - $95.75 $162,478 - $272,696	-2,848 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$68.3 - $93.8 $194,518 - $267,142	2,848 New	2,848 $240,000
Q3 2019 Oct 16, 2019	SELL	$61.86 - $97.8 $235,377 - $372,129	-3,805 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$42.22 - $63.23 $160,647 - $240,590	3,805 New	3,805 $241,000
Q3 2018 Nov 08, 2018	SELL	$32.0 - $52.4 $246,400 - $403,480	-7,700 Closed	0 $0
Q2 2018 Jul 13, 2018	BUY	$19.85 - $32.0 $152,845 - $246,400	7,700 New	7,700 $241,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.